Violation Tracker Summary for Primary Offense Type

Offense Type: 
False Claims Act and related
Penalty Total since 2000: 
$47,097,771,445
Number of Penalty Records: 
2,925
Note: 
The totals here are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Tenet Healthcare$1,639,060,00016
HCA Healthcare$1,536,737,05813
Takeda Pharmaceutical$1,246,349,91010
Wells Fargo$1,204,046,7862
Pfizer$1,161,001,89223
DaVita HealthCare Partners$1,133,700,0005
Viatris$960,447,70027
Boeing$954,303,63313
Bechtel$911,475,0004
Merck$818,033,33315


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Parent Parent Major Industrysort icon Year Agency Penalty Amount
Forest Laboratories AbbVie pharmaceuticals 2013 TX-AG $3,000,000
Forest Laboratories LLC AbbVie pharmaceuticals 2016 MULTI-AG (*) $2,500,000
Forest Laboratories, Inc. AbbVie pharmaceuticals 2012 ID-AG $790,000
Forest Pharmaceuticals Inc. AbbVie pharmaceuticals 2010 MULTI-AG (*) $60,000,000
Forest Pharmaceuticals Inc. AbbVie pharmaceuticals 2012 KY-AG $1,750,000
Genentech Inc. Roche pharmaceuticals 2016 MULTI-AG (*) $2,200,000
Genzyme Corp. Sanofi pharmaceuticals 2013 MULTI-AG (*) $22,280,000
Gilead Sciences Gilead Sciences pharmaceuticals 2013 LA-AG $250,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2003 MULTI-AG $40,000,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2005 MULTI-AG (*) $10,000,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2006 GA-AG $418,952
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2012 ID-AG $2,600,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2011 KS-AG $4,250,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2012 LA-AG $10,000,000
GlaxoSmithKline LLC GlaxoSmithKline pharmaceuticals 2010 HI-AG $3,333,333
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2006 MULTI-AG $70,000,000
Immunex Corp. Amgen pharmaceuticals 2009 IA-AG $357,000
IVAX Pharmaceuticals Teva Pharmaceutical Industries pharmaceuticals 2009 MULTI-AG (*) $5,400,000
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. Johnson & Johnson pharmaceuticals 2012 KY-AG $7,000,000
Johnson & Johnson Johnson & Johnson pharmaceuticals 2013 LA-AG $10,000,000
Johnson & Johnson et al. Johnson & Johnson pharmaceuticals 2010 HI-AG $5,200,000
Johnson & Johnson, Janssen Pharmaceutical Products LP, Ortho-McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP, McNeil-PPC, Inc. and Centocor, Inc. Johnson & Johnson pharmaceuticals 2011 ID-AG $2,000,000
King Pharmaceuticals Pfizer pharmaceuticals 2006 MULTI-AG (*) $124,000,000
KV Pharmaceutical Company KV Pharmaceutical pharmaceuticals 2012 MULTI-AG (*) $17,000,000
Mallinckrodt LLC Mallinckrodt pharmaceuticals 2013 MULTI-AG (*) $3,500,000
Merck Merck pharmaceuticals 2008 MULTI-AG (*) $290,000,000
Merck & Co., Inc. Merck pharmaceuticals 2011 MA-AG $24,000,000
Merck and Company, Inc. Merck pharmaceuticals 2011 WI-AG $4,250,000
Merck Sharp & Dohme Corp Merck pharmaceuticals 2010 HI-AG $28,000,000
Merck Sharp & Dohme Corp. Merck pharmaceuticals 2011 ID-AG $1,600,000
Merck Sharp & Dohme Corp. Merck pharmaceuticals 2012 KY-AG $6,000,000
Mylan Inc. Viatris pharmaceuticals 2017 MULTI-AG (*) $465,000,000
Mylan Inc. Viatris pharmaceuticals 2010 MA-AG $2,600,000
Mylan Laboratories Inc. Viatris pharmaceuticals 2010 TX-AG $23,000,000
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. Viatris pharmaceuticals 2012 ID-AG $625,000
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. Viatris pharmaceuticals 2011 KY-AG $6,500,000
Mylan Pharmaceuticals, Inc. Viatris pharmaceuticals 2009 MULTI-AG (*) $118,000,000
Novartis Novartis pharmaceuticals 2013 LA-AG $7,000,000
Novartis Pharmaceuticals Corp. Novartis pharmaceuticals 2013 ID-AG $750,000
Novartis Pharmaceuticals Corp. Novartis pharmaceuticals 2012 KY-AG $2,750,000
Novartis Pharmaceuticals Corporation Novartis pharmaceuticals 2010 HI-AG $3,333,333
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2017 MULTI-AG (*) $3,320,963
Ortho-McNeil Pharmaceutical, Inc. Johnson & Johnson pharmaceuticals 2009 MULTI-AG (*) $3,400,000
OSI Pharmaceuticals LLC Astellas Pharma pharmaceuticals 2016 DOJ_CIVIL $33,500,000
OSI Pharmaceuticals LLC Astellas Pharma pharmaceuticals 2016 MULTI-AG (*) $2,200,000
Par Pharmaceutical Endo International pharmaceuticals 2013 LA-AG $6,000,000
Par Pharmaceutical Co. Endo International pharmaceuticals 2011 MS-AG $2,010,667
Par Pharmaceutical Cos., Inc. Endo International pharmaceuticals 2011 ID-AG $1,700,000
Par Pharmaceutical Inc. Endo International pharmaceuticals 2011 KY-AG $4,500,000
Par Pharmaceutical, Inc. Endo International pharmaceuticals 2010 MA-AG $500,000
Par Pharmaceuticals, Inc. Endo International pharmaceuticals 2011 MULTI-AG $154,000,000
Pernix Therapeutics Currax Pharmaceuticals pharmaceuticals 2013 LA-AG $800,000
Perrigo Perrigo pharmaceuticals 2013 LA-AG $2,000,000
Pfizer Inc. Pfizer pharmaceuticals 2002 MULTI-AG (*) $21,084,700
Pfizer Inc. Pfizer pharmaceuticals 2011 MULTI-AG (*) $2,621,154
Pfizer Inc. Pfizer pharmaceuticals 2013 TX-AG $18,170,000
Pfizer Inc. and Pharmacia Corp. Pfizer pharmaceuticals 2012 ID-AG $2,900,000
Pfizer, Inc. and Pharmacia Corporation Pfizer pharmaceuticals 2010 HI-AG $8,200,000
Pharmacia Corp. Pfizer pharmaceuticals 2009 OH-AG $400,000
Pharmacia Corporation Pfizer pharmaceuticals 2011 NY-AG $2,500,000
Pharmacia Corporation Pfizer pharmaceuticals 2013 WI-AG $29,453,247
Purdue Frederick Co. Purdue Pharma pharmaceuticals 2008 TX-AG $1,600,000
Purdue Frederick Company Inc. Purdue Pharma pharmaceuticals 2007 MULTI-AG (*) $160,000,000
Purepac Pharmaceutical Co. Pfizer pharmaceuticals 2010 ID-AG $600,000
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC Pfizer pharmaceuticals 2011 MS-AG $2,010,667
Ranbaxy Sun Pharmaceuticals pharmaceuticals 2013 LA-AG $5,000,000
Ranbaxy Pharmaceuticals, Inc. et al. Sun Pharmaceuticals pharmaceuticals 2014 TX-AG $17,875,000
Roxane Laboratories Inc. Hikma Pharmaceuticals pharmaceuticals 2009 OH-AG $2,400,000
Roxane Laboratories, Inc. Hikma Pharmaceuticals pharmaceuticals 2009 FL-AG $8,500,000
Roxane Laboratories, Inc. Hikma Pharmaceuticals pharmaceuticals 2009 IA-AG $357,000
Roxane, Inc. Hikma Pharmaceuticals pharmaceuticals 2010 MO-AG $3,100,000
Roxanne Laboratories and Boehringer Ingelheim Hikma Pharmaceuticals pharmaceuticals 2008 AL-AG $9,500,000
Sandoz Novartis pharmaceuticals 2009 KY-AG $16,000,000
Sandoz Novartis pharmaceuticals 2013 LA-AG $13,100,000
Sandoz Inc. Novartis pharmaceuticals 2010 ID-AG $1,650,000
Sandoz, Inc. Novartis pharmaceuticals 2011 MS-AG $30,110,618
Sanofi-Aventis U.S. LLC Sanofi pharmaceuticals 2012 ID-AG $828,500
Schering-Plough Merck pharmaceuticals 2012 LA-AG $5,000,000
Schering-Plough Merck pharmaceuticals 2008 MO-AG $31,000,000
Schering-Plough Corp. Merck pharmaceuticals 2004 TX-AG (*) $27,000,000
Schering-Plough Corporation Merck pharmaceuticals 2009 CA-AG $21,300,000
Schwarz Pharma Inc. UCB pharmaceuticals 2010 MULTI-AG (*) $9,756,164
Shering-Plough/Warrick Companies Merck pharmaceuticals 2009 AL-AG $14,833,333
Shire Takeda Pharmaceutical pharmaceuticals 2013 LA-AG $4,000,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical pharmaceuticals 2017 MULTI-AG (*) $6,104,000
SmithKline Beecham Corp. GlaxoSmithKline pharmaceuticals 2007 TX-AG $1,400,000
Takeda Pharmaceuticals Takeda Pharmaceutical pharmaceuticals 2008 AL-AG $2,000,000
Takeda/Tap Pharmaceuticals Takeda Pharmaceutical pharmaceuticals 2013 LA-AG $3,750,000
TAP Pharmaceutical Products Takeda Pharmaceutical pharmaceuticals 2011 PA-AG $5,240,797
TAP Pharmaceutical Products, Inc. Takeda Pharmaceutical pharmaceuticals 2001 AR-AG $525,780
TAP Pharmaceutical Products, Inc. Takeda Pharmaceutical pharmaceuticals 2001 MULTI-AG (*) $25,516,440
Taro Pharmaceutical Industries Taro Pharmaceutical Industries pharmaceuticals 2013 LA-AG $5,000,000
Taro Pharmaceuticals USA, Inc. Taro Pharmaceutical Industries pharmaceuticals 2014 TX-AG $8,750,000
Teva Pharmaceutical USA, Inc. Teva Pharmaceutical Industries pharmaceuticals 2009 MA-AG $7,000,000
TEVA Pharmaceuticals USA Teva Pharmaceutical Industries pharmaceuticals 2009 AL-AG $14,833,333
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. Teva Pharmaceutical Industries pharmaceuticals 2010 KY-AG $10,000,000
Teva Pharmaceuticals USA, Inc. et al. Teva Pharmaceutical Industries pharmaceuticals 2010 HI-AG $6,500,000
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. Teva Pharmaceutical Industries pharmaceuticals 2010 ID-AG $1,900,000
Teva Pharmaceuticals Inc. Teva Pharmaceutical Industries pharmaceuticals 2010 MULTI-AG $169,000,000
UCB UCB pharmaceuticals 2013 LA-AG $3,350,000
Warner Chilcott PLC AbbVie pharmaceuticals 2015 MULTI-AG (*) $10,600,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
(*): Some penalties are partial or complete duplicates of other penalty records, either because a DOJ settlement duplicates an agency record or because EPA listed the full penalty for a company for each of the company's relevant facilities. Penalty amounts marked with an asterisk have been identified by Good Jobs First as duplicating other penalty amounts.